x

Cadrenal Therapeutics, Inc. (Nasdaq:CVKD)

Health Care/Life Sciences • Pharmaceuticals
CIK 1937993
Company

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focused on developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang Pham on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Address
822 A1A North
Suite 320
Ponte Vedra Beach, Florida 32082
Employees
3
Stock Info
Close
$0.6490
Day Range
0.6235 - 0.6800
52 Week Range
0.3950 - 3.1400
Average volume
349.83K
Short Interest
23.82K (02/15/24)
% of Float Shorted
0.44%
Market Cap
$8.66M
Revenue
N/A
Net Income
-$6.71M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$1.0370
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman & Chief Executive Officer
Quang X Pham
Director
Robert Lisicki
Independent Director
John R Murphy MBA, CPA
Independent Director
Steven L Zelenkofske MD
Independent Director
Glynn Wilson PhD
SEC filings
DateFormEvent
20 Dec, 2024 424B5
25 Nov, 2024 424B3
22 Nov, 2024 EFFECT
14 Nov, 2024 S-3
14 Nov, 2024 D
14 Nov, 2024 SC 13G/A
7 Nov, 2024 10-Q
7 Nov, 2024 8-K
4 Nov, 2024 8-K
4 Nov, 2024 424B5
24 Oct, 2024 8-K
4 Oct, 2024 SC 13G
25 Sep, 2024 8-K
5 Sep, 2024 8-K
20 Aug, 2024 8-K
16 Aug, 2024 8-K
8 Aug, 2024 8-K
7 Aug, 2024 10-Q
6 Aug, 2024 8-K
31 Jul, 2024 8-K
12 Jun, 2024 DEFA14A
11 Jun, 2024 DEF 14A
11 Jun, 2024 ARS
29 May, 2024 PRE 14A
9 May, 2024 10-Q
9 May, 2024 8-K
10 Apr, 2024 4
9 Apr, 2024 8-K
3 Apr, 2024 3
3 Apr, 2024 4
2 Apr, 2024 POS AM
2 Apr, 2024 EFFECT
20 Mar, 2024 EFFECT
18 Mar, 2024 CORRESP
15 Mar, 2024 UPLOAD
12 Mar, 2024 S-3
12 Mar, 2024 S-8
12 Mar, 2024 8-K
11 Mar, 2024 10-K
11 Mar, 2024 8-K
5 Mar, 2024 8-K
15 Feb, 2024 8-K/A
14 Feb, 2024 SC 13G
13 Feb, 2024 SC 13G/A
12 Feb, 2024 4
12 Feb, 2024 SC 13G
12 Feb, 2024 8-K
9 Nov, 2023 8-K
9 Nov, 2023 10-Q
23 Oct, 2023 8-K
6 Oct, 2023 4
8 Sep, 2023 8-K
6 Sep, 2023 4
5 Sep, 2023 4
31 Aug, 2023 DEFA14A
31 Aug, 2023 DEFA14A
28 Aug, 2023 ARS
28 Aug, 2023 DEF 14A
18 Aug, 2023 8-K
16 Aug, 2023 8-K
16 Aug, 2023 424B3
10 Aug, 2023 8-K
10 Aug, 2023 10-Q
1 Aug, 2023 424B3
28 Jul, 2023 EFFECT
26 Jul, 2023 CORRESP
26 Jul, 2023 UPLOAD
24 Jul, 2023 4
24 Jul, 2023 8-K
24 Jul, 2023 3
24 Jul, 2023 S-1
18 Jul, 2023 D
26 May, 2023 8-K
10 May, 2023 10-Q
10 May, 2023 8-K
31 Mar, 2023 3/A
30 Mar, 2023 10-K
27 Mar, 2023 8-K
27 Mar, 2023 SC 13G
22 Mar, 2023 4
16 Mar, 2023 4
13 Feb, 2023 4
25 Jan, 2023 8-K
24 Jan, 2023 4
24 Jan, 2023 S-8
24 Jan, 2023 4
24 Jan, 2023 4
23 Jan, 2023 424B4 IPO completed
23 Jan, 2023 424B4
20 Jan, 2023 SEC STAFF
20 Jan, 2023 CERT
19 Jan, 2023 3
19 Jan, 2023 3
19 Jan, 2023 EFFECT
19 Jan, 2023 3
19 Jan, 2023 3
19 Jan, 2023 3
19 Jan, 2023 3
17 Jan, 2023 CORRESP
17 Jan, 2023 CORRESP
17 Jan, 2023 S-1/A
17 Jan, 2023 8-A12B
28 Dec, 2022 S-1/A
8 Dec, 2022 S-1/A
8 Dec, 2022 UPLOAD
8 Dec, 2022 D
8 Dec, 2022 CORRESP
6 Dec, 2022 S-1/A
17 Oct, 2022 CORRESP
17 Oct, 2022 S-1/A
13 Oct, 2022 UPLOAD
12 Oct, 2022 SEC STAFF
11 Oct, 2022 S-1/A
22 Sep, 2022 S-1
22 Sep, 2022 CORRESP
2 Sep, 2022 DRS/A
2 Sep, 2022 DRSLTR
30 Aug, 2022 UPLOAD
23 Aug, 2022 DRSLTR
23 Aug, 2022 DRS/A
11 Aug, 2022 UPLOAD
25 Jul, 2022 D
15 Jul, 2022 DRS
Last update:2024-03-06 12:39:47.181904
Cadrenal Therapeutics, Inc. by TradingView

Sign Up to Subscribe